The publication of University of Health Sciences Istanbul Sisli Hamidiye Etfal Application and Research Center.


Online article submission system has been turned over to eJManager. We kindly request you to submit your current article or new articles via eJManager system

          VOLUME 34 / ISSUE 1


The Journal is Indexed in


11 - Summaries Of Treatment Of Breast Cancer in Our Clinic

Didem Kara Çeten, Orhan Kızılkaya, Alpaslan Mayadaglı, Oktay İncekara

OBJECTIVE: in this study, we have evaulate, retrospectively, the treatment of 327 patients who had been diagnosed with Breast Cancer.

STUDY DESIGN: 327 patients who reciev·e:d treatments ( Radiotherapy, systematic chemotheraphy, horomonetheraphy and combined therapies) had been stuided under prognostic factors and /oca/-regional reoccurance but also in distant metastatic occurance periods.

RESULTS: 245 patients recieved adjacent-external­radiotherapy (4600 6000 cGy), 72 patient recieved no radiotheraphy and 10 patients stopped radiotherapy, before comp/etion. 208 patients received adjuvan systematic chemotheraphy (CMF or FFEC), 263 patients received adjuvan hormonotherahpy (Tamoksifen 20 mglday.). 20.1 %of the patient (65 people) received only radiotherahpy, 6.7 % (22 people) only chemothrepahy, 49.5 % (162 people) radiotheraphy+chemotheraphy, 7.3% (24 people) chemotheraphy+hormonotheraphy and 8.2% (28 people) received radio theraphy+hormonotheraphy.

CONCULSION: Distant metastases had been /east observed in patients who received: Surgury+radiotherapy+chemotherapy, patiens receivinğ combined treatment methods approximaıely 70% survial rates

Keywords: Breast Cancer, Chemotheraphy, Radiotheraphy, Hormonotheraphy

To read full article click


Home Page       Editorial       Editorial Board       Advisory Board       Information for Authors       Contact       Archive

Copyright ® 2011 Sisli Etfal Hastanesi Tıp Bülteni